論文・総説 - 稲次　基希

分割表示  618 件中 101 - 120 件目  ／  全件表示 >>

  1. Toshiya Momose, Tadashi Nariai, Takuya Kawabe, Motoki Inaji, Yoji Tanaka, Shinya Watanabe, Taketoshi Maehara, Keiichi Oda, Kenji Ishii, Kiichi Ishiwata, Masaaki Yamamoto. Clinical benefit of 11C methionine PET imaging as a planning modality for radiosurgery of previously irradiated recurrent brain metastases. Clin Nucl Med. 2014.11; 39 (11): 939-943. ( PubMed, DOI )

  2. Momose Toshiya, Nariai Tadashi, Kawabe Takuya, Inaji Motoki, Tanaka Yoji, Watanabe Shinya, Maehara Taketoshi, Oda Keiichi, Ishii Kenji, Ishiwata Kiichi, Yamamoto Masaaki. Clinical Benefit of C-11 Methionine PET Imaging as a Planning Modality for Radiosurgery of Previously Irradiated Recurrent Brain Metastases CLINICAL NUCLEAR MEDICINE. 2014.11; 39 (11): 939-943.

  3. Tamura Kaoru, Inaji Motoki, Nariai Tadashi, Tamaki Masashi, Hirai Sakyo, Saigusa Kuniyasu, Tanaka Yoji, Maehara Taketoshi. MONITORING OF BIOLOGICAL RESPONSE TO BEVACIZUMAB IN MALIGNANT GLIOMA PATIENTS BASED ON L-[methyl-11C] METHIONINE-POSITRON EMISSION TOMOGRAPHY NEURO-ONCOLOGY. 2014.11; 16 ( DOI )

  4. Nariai T., Inaji M., Tanaka Y., Ishii Y., Mukawa M., Hayashi S., Oda K., Ishiwata K., Ishii K.. Treatment of adult patients with moyamoya disease based on hemodynamic measurement with perfusion MRI and PET and indirect bypass procedures INTERNATIONAL JOURNAL OF STROKE. 2014.10; 9 140.

  5. Nariai T., Tanaka Y., Ishii Y., Hara S. M., Ueda Y., Momose T., Ito N., Hayashi S., Mukawa M., Inaji M.. Treatment of juvenile patients with moyamoya disease based on noninvasive measurement of cerebral perfusion with mri INTERNATIONAL JOURNAL OF STROKE. 2014.10; 9 272.

  6. Mullah Saad, Urmy Jahanara, Inaji Motoki, Nariai Tadashi, Ishibashi Satoru, Ohno Kikuo. Attenuation of brain injury induced cognitive dysfunction and hyperlocomotion: Chronic administration enhanced the effects of adenosine A2A receptor antagonist BRAIN INJURY. 2014.05; 28 (5-6): 744.

  7. Yosuke Ishii, Tadashi Nariai, Yoji Tanaka, Maki Mukawa, Motoki Inaji, Taketoshi Maehara, Kikuo Ohno. Practical clinical use of dynamic susceptibility contrast magnetic resonance imaging for the surgical treatment of moyamoya disease. Neurosurgery. 2014.03; 74 (3): 302-309. ( PubMed, DOI )

  8. Saad Habib-E-Rasul Mullah, Ryo Komuro, Ping Yan, Shihori Hayashi, Motoki Inaji, Yoko Momose-Sato, Leslie M Loew, Katsushige Sato. Evaluation of voltage-sensitive fluorescence dyes for monitoring neuronal activity in the embryonic central nervous system. J. Membr. Biol.. 2013.09; 246 (9): 679-688. ( PubMed, DOI )

  9. 稲次 基希, 前原 健寿, 林 志保里, 橋本 聡華, 原 恵子, 松浦 雅人. 難治性てんかん患者に対する焦点切除術の精神状態とけいれん無発症に関する成績(Psychiatric condition and seizure-free outcome of focus resection for Patients with intractable epilepsy) てんかん研究. 2013.09; 31 (2): 391. ( 医中誌 )

  10. Keiko Hara, Taketoshi Maehara, Miho Miyajima, Katsuya Ohta, Hiroko Iino, Motoki Inaji, Ayasa Matsuda, Eisuke Matsushima, Minoru Hara, Masato Matsuura. Post-operative mismatch negativity recovery in a temporal lobe epilepsy patient with cavernous angioma. Clin Neurol Neurosurg. 2013.06; 115 (6): 756-759. ( PubMed, DOI )

  11. Maehara Taketoshi, Inaji Motoki, Matsuura Masato. Surgical Effects of Focus Resection for Patients With Intractable Epilepsy NEUROLOGIA MEDICO-CHIRURGICA. 2013.05; 53 (5): 281-286.

  12. Maehara Taketoshi, Inaji Motoki, Matsuura Masato. てんかん手術の長期機能予後 難治性てんかん患者に対する焦点切除術の外科的効果(Long-Term Functional Outcome of Epilepsy Surgery Surgical Effects of Focus Resection for Patients With Intractable Epilepsy) Neurologia medico-chirurgica. 2013.05; 53 (5): 281-286. ( 医中誌 )

  13. Taketoshi Maehara, Motoki Inaji, Masato Matsuura. Surgical effects of focus resection for patients with intractable epilepsy. Neurol. Med. Chir. (Tokyo). 2013; 53 (5): 281-286. ( PubMed, DOI )

  14. Saad Habib-E-Rasul Mullah, Motoki Inaji, Tadashi Nariai, Satoru Ishibashi, Kikuo Ohno. A selective adenosine A2A receptor antagonist ameliorated hyperlocomotion in an animal model of lateral fluid percussion brain injury. Acta Neurochir. Suppl.. 2013; 118 89-92. ( PubMed, DOI )

  15. Tadashi Nariai, Motoki Inaji, Yoji Tanaka, Mikio Hiura, Chihiro Hosoda, Kenji Ishii, Kikuo Ohno. PET molecular imaging to investigate higher brain dysfunction in patients with neurotrauma. Acta Neurochir. Suppl.. 2013; 118 251-254. ( PubMed, DOI )

  16. Sato Katsushige, Mullah Saad Habib-E-Rasul, Inaji Motoki, Nariai Tadashi, Momose-Sato Yoko, Ohno Kikuo. Developmental changes in the LTP in the neonatal rat corticostriatal projection : Optical imaging with the voltage-sensitive dye JOURNAL OF PHYSIOLOGICAL SCIENCES. 2013; 63 S127.

  17. Maki Mukawa, Tadashi Nariai, Yoshiharu Matsushima, Yoji Tanaka, Motoki Inaji, Taketoshi Maehara, Masaru Aoyagi, Kikuo Ohno. Long-term follow-up of surgically treated juvenile patients with Moyamoya disease. J Neurosurg Pediatr. 2012.11; 10 (5): 451-456. ( PubMed, DOI )

  18. Shigeta Keigo, Ohno Kikuo, Takasato Yoshio, Masaoka Hiroyuki, Hayakawa Takanori, Yatsushige Hiroshi, Inaji Motoki, Sumiyoshi Kyoko, Momose Toshiya, Maeda Takuya, Kiyokawa Jyuri. 急性脳梗塞患者のDWI ASPECTSと再開通転帰の分析(Analysis of DWI ASPECTS and Recanalization Outcomes of Patients with Acute-phase Cerebral Infarction) Journal of Medical and Dental Sciences. 2012.06; 59 (2): 57-63. ( 医中誌 )

  19. 成相 直, 稲次 基希, 豊原 潤, 石渡 喜一, 田中 洋次, 青柳 傑, 大野 喜久郎. 脳腫瘍に対する治療戦略の新しい展望　分子解析に基づく臨床試験 脳腫瘍におけるDNA合成を測定するための新しいPET分子イメージングプローブとしての4DSTの臨床利用(New Horizon of Treatment Strategy for Brain Tumor: Clinical Trial Based on Molecular Analyses Clinical Use of 4DST as a New PET Molecular Imaging Probe to Measure DNA Synthesis of Brain Tumor) Brain Tumor Pathology. 2012.05; 29 (Suppl.): 151. ( 医中誌 )

  20. ムラサド・ハビブ , 稲次 基希, 成相 直, 大野 喜久郎. 神経損傷の基礎シンポジウム Lateral fluid percussion modelの行動異常に対するアデノシンA2A受容体アンタゴニストの効果 日本脳神経外傷学会プログラム・抄録集. 2012.03; 35回 51. ( 医中誌 )

< 前のページ - 次のページ >

このページの先頭へ▲